Identifying Hypercortisolism in Patients with Resistant Diabetes - Episode 8

Pathophysiology of Hypercortisolism

Published on: May 13, 2024

Hanford Yau, MD , Ralph DeFronzo, MD , Pam Kushner, MD , Honey East, MD, Christopher Lucci, MD

Medical experts offer a comprehensive overview of the pathophysiology of hypercortisolism, detailing its impact on β-cell dysfunction and reduced insulin sensitivity, and discuss the potential role of GLP-1 treatment in managing the condition.

EP. 1: Defining Resistant Diabetes

EP. 2: Differentiating Medication Non-Adherence From Underlying Comorbidities

EP. 3: Barriers to Accessing New Anti-Diabetes Medications

EP. 4: Suspecting Hypercortisolism in Patients With Resistant Diabetes

EP. 5: Testing for Hypercortisolism

EP. 6: Patient Subgroups With a Higher Prevalence of Hypercortisolism

EP. 7: Evolving Perception of Autonomous Adrenal Hypercortisolism

Now Viewing

EP. 8: Pathophysiology of Hypercortisolism

EP. 9: Need to Address Underlying Hypercortisolism

EP. 10: Approaching Treatment in Hypercortisolism

EP. 11: Choosing Between Medical and Surgical Options for Hypercortisolism

EP. 12: Long-Term Outcomes for Patients Treated for Hypercortisolism